CABI has announced that Dr. Daniel Elger has been appointed as the next Chief Executive Officer of CAB International (‘CABI’) in succession to Dr Trevor Nicholls on his retirement. Dr. Elger will take-up his new postion on September 1, 2020.
Dr. Elger has over twenty-five years of experience in the life sciences sector, including fifteen years at senior management/board level in medical biotech, mainly in public companies. He has a passion for scientific innovation and a clear focus on maximising the benefits to society by ensuring the rapid development of, and broad access to, the resulting products and technologies. He has worked with a wide range of external partners and collaborators, including, healthcare professionals and academics, scientific societies, government, regulatory and charitable bodies, across diverse international settings.
Dr Elger joins CABI from Summit Therapeutics plc. where he was Senior Vice President R&D and Chief Commercial Officer.
This appointment was made after a full and rigorous international search conducted for CABI by Kincannon & Reed as their search partner.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.